Moreover, when challenged with a B cell tumor designed to mimic Burkitt lymphoma 14 days after receiving the boost, mice in the Adeno–E1-LMP plus MVA-IiE1 had lower levels of EBV DNA than PBS-treated mice, and greater than 1⁄2 the mice remained tumor free. This evidence concerns the gene PDLIM7 and neoplasm.